Form 4: Veracyte CFO Rebecca Chambers Reports Acquisition and Disposal of Common Stock

Rebecca Chambers, CFO of Veracyte, Inc., reported the acquisition of 59,856 shares of common stock and the disposal of 144,573 shares on March 6, 2024.

Summary

• On March 6, 2024, Rebecca Chambers, the Chief Financial Officer of Veracyte, Inc., acquired 59,856 shares of common stock.
• On the same day, Ms. Chambers disposed of 144,573 shares of common stock.
• Following these transactions, Ms. Chambers beneficially owns 144,573 shares of Veracyte common stock.
• The acquisition of 59,856 shares was related to restricted stock units awarded on March 6, 2024, which vest 25% on March 2, 2025, and then 1/16 per quarter thereafter, contingent upon continued employment.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Future Outlook

The restricted stock units vest over time, contingent upon continued employment, indicating a long-term incentive for the CFO.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in publicly traded companies. It provides transparency to investors regarding the actions of key executives.

Stakeholder Impact

• Shareholders are informed about the CFO's stock transactions, providing transparency into insider activity.

Key Dates